Ningbo Menovo Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 246.32 million compared to CNY 500.21 million a year ago. Revenue was CNY 246.32 million compared to CNY 500.21 million a year ago.

Net income was CNY 43.45 million compared to CNY 115.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.544 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.5011 a year ago.